Hugh McMillan
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (NCT02876094) | Hugh McMillan | 2019-01-29 |
Track Hugh McMillan automatically
Every clearance here is in the API, with alerts when new ones post.